Asian Journal of Research and Reports in Hepatology

Comparison of GFR Determined by Using Serum Cystatin C and Serum Creatinine Concentration Alone and in Combination for Diagnosis of Hepatorenal Syndrome

Asma Helen Khan *

Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

Nooruddin Ahmad

Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

Mamun Al Mahtab

Interventional Hepatology Division, Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

Shahinul Alam

Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

*Author to whom correspondence should be addressed.

---

Abstract

Introduction: Renal dysfunction is common in patients with liver cirrhosis, occurs about 19% of hospitalized patients with cirrhosis which have a huge impact on prognosis. Serum creatinine (Cr) is a widely used but less reliable marker to estimate glomerular filtration rate (GFR). Serum cystatin C(CysC) is a good endogenous marker to determine early renal impairment. Combined cystatin C and creatinine is an effective reflection of GFR. This study aimed to validate renal function by estimation of GFR using serum cystatin C and serum creatinine individually and combinedly. Methods: This was an observational cross sectional study, conducted in Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. Thirty patients were cirrhosis with hepatorenal syndrome (HRS) and thirty were cirrhosis without HRS.

Results: Mean value of serum creatinine, serum cystatin C, GFR by creatinine, GFR by cystatin C and GFR by (cre-cys) were statistically significant (p<0.05) between two groups. All the study population were in Child Pugh B and C. Association of mean values of creatinine, cystatin C, GFR by creatinine, GFR by cystatin C and GFR by (cre-cys) with Child Pugh B and C were statistically significant in both groups. Based on ROC curves at cut-off value of 1.29 mg/ml cystatin C had sensitivity 96.7% and specificity 76.7% for detecting HRS. Coefficient of GFR by creatinine was -0.01 (CI -0.01 to 0.00) which was not statistically significant. Coefficient of GFR by cystatin C was -0.02 (CI -0.03 to 0.00) and GFR by (cre-cys) was 0.04 (CI 0.01 to 0.06) which were statistically significant for diagnosis of HRS.

Conclusion: Combined serum creatinine and cystatin C based GFR showed significant association to discriminate early renal impairment in patients with cirrhosis of liver.

Keywords: Serum cystatin C, serum creatinine, hepatorenal syndrome, renal dysfunction

---

---

---

References

Slack A, Yeoman A, Wendon J, Renal dysfunction in chronic liver disease, Critical Care, vol 2010;14(2):214.

Moore K, Wendon J, Frazer M, Karani J, Williams R,Badr K. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med. 1992;327:1774-1778.

Arroyo V, Fernandez J, Gines P. Pathogenesis and treatment of hepatorenal syndrome. Seminars in Liver Disease; 28(1):81-95 2008.

Lenz K.HRS: is it normal hypovolemia, a cardiac disease of part Gradually Developing multiorgan dysfunction? Hepatology. 2005:263-264.

Ahn HS, Kim YS, Kim SG. Cystatin C is a good predictor of hepatorenal syndro and survival in patients with cirrhosis who have normal serum creatinine level. Hepato Gastroenterology. 2012;59(116):1168-117.

J Mac A Ualy, K Thompson B, A Kiberd, D C Barnes,K M Peltekian. Serum creatinine in patients with advanced liver disease is of limited value for identification of moderate renal dysfunction:are the equations for estimating renal function better? Canadian Journal of Gastroenterology. 2006;20(8):521-526.

Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function-a review. Clin Chem. Lab Med. 1999;37:389-395.

Sjostrom P, Tidman M, Jones I. Determination of the production rate and non-renal clearance of cystatin C and estimation of glomerular filtration rate from the serum concentration of cystatin C in human. Scand J Clin Lab Invest. 2005;65: 111-124.

Demirtas S, Barbas A, Akbay A, Yavuz Y, Karaca L.Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome.Clin Chem Acta. 2001;311:81-89.

Salerno F, Gerbes A, Gines P, Wong F,Arroyo V.Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut. 2007;56:1310-1318.

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration. Ann Intern Med. 1999;130(6):461-70.

Stevens LA, Coresh J, Schmid CH, Feldman HI, Froissart M, Kusek J et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51(3):395-406.

Mindikoglu AL, Dowling TC, Weir MR, Seliger SL, Christenson RH, Magder LS. Performance of Chronic Kidney Disease Epidemiology Collaboration Creatinine-CystatinC Equation for Estimating Kidney Function in Cirrhosis. Hepatology. 2014; 59(4):1532-1542.

Murty MSN, Sharma UK. Pandey UB,Kankare SB .Serum cystatinC as a marker of renal function in detection of early acute kidney injury. Indian J Nephrol 2013;23(3):180-183.

Culafic D, Stulic M, Obrenovic R, Miletic D, Mijac D, Stojkovic M et al. Role of cystatin Cand renal resistive index in assessment of renal function in patients with liver cirrhosis. World Gastroenterol 2014;20 (21):6573-6579.

El-Agroudy A, Sabry AA, Ghanem HA, El-Baz A, Fakhry A, Gad HM et al. Serum cystatin C: a good marker for evaluation of glomerular filtration rate in hepatorenal syndrome. Eur J Gen Med. 2004;1(4):29-35.

Omar M, Abdel-Razek W, Aba-Raia G, Assem M, El-Azab G. Evaluation of serum cystatin C as a marker of early renal impairment in patient with liver cirrhosis. International Journal of Hepatology. 2015:1-8.

Woitas RP, Stoffel-Wagner B, Flommersfeld S, Poege U, Schiedermaier P, Klehr HU et al. Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem 2000;46:712-715.

Gerbes AL, Gulberg V, Bilzer M, Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of liver. Gut. 2002;50(1):106-110.

Herget-Rosenthal S, Metzger J, Albalat A, Bitsika V, Mischak H. Proteomic biomarkers for the early detection of acute kidney injury. Prilozi. 2012;33(1):27-48.

Wang D, Feng JF, Wang AQ, Yang YW, Liu YS. Role of cystatin C and glomerular filtration rate in diagnosis of kidney impairment in hepatic cirrhosis patients .Medicine (Wolters Kluwer Health). 2017; 96:20(e6949).